Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
ENHANCED GENOMICS LIMITED
Active- 12423696Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Enhanced Genomics St John's Innovation Centre, Cowley Road, Cambridge CB4 0WS
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 25/09/2026View PDF (14 pages)
Total exemption full accounts made up to 2025-12-31
- 01/06/2026View PDF (9 pages)
Statement of capital following an allotment of shares on 2026-05-22
- 30/04/2026View PDF (1 pages)
Registered office address changed from Suite 1, the Jeffreys Building, St John's Innovation Park Cowley Road Cambridge Cambridgeshire CB4 0DS United Kingdom to Enhanced Genomics St John's Innovation Centre Cowley Road Cambridge CB4 0WS on 2026-04-30
- 21/03/2026View PDF (1 pages)
Resolutions
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 4 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 03/02/2027
- Last statement dated
- 31/12/2024
Financial performance
The latest figures ENHANCED GENOMICS LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£3.69M2024
-48.12%vs 20232023: £7.12M
Total Assets
£4.61M2024
-43.71%vs 20232023: £8.20M
Cash in Bank
£1.93M2024
-70.16%vs 20232023: £6.48M
Total Liabilities
£346.53K2024
-2.58%vs 20232023: £355.71K
Employees
282024
+7vs 20232023: 21
Of the 4 measures with an earlier filing to compare against, 4 fell. Cash in bank moved furthest, down 70.16% on 2023. See the full financial analysis for ENHANCED GENOMICS LIMITED.
The full financial record
Four ways through ENHANCED GENOMICS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -38.6% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 28 | +7 |
| 2023 | 21 | +9 |
| 2022 | 12 | +4 |
| 2021 | 8 | – |
Reported employee count increased from 8 in 2021 to 28 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
19Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Corporate Director | 25/08/2022–Present | 88 | |
| Director | 25/08/2022–01/04/2025 | 2 | |
| Director | 25/08/2022–14/10/2022 | 26 | |
| Director | 24/01/2020–08/12/2020 | 1 | |
| Director | 30/03/2021–25/08/2022 | 17 | |
| Director | 24/01/2020–25/08/2022 | 1 | |
| Director | 24/01/2020–26/03/2021 | 1 | |
| Director | 04/01/2021–25/08/2022 | 13 | |
| Secretary | 28/05/2021–16/05/2024 | 0 | |
| Director | 05/08/2020–07/12/2023 | 0 | |
| Director | 30/03/2021–11/11/2024 | 0 | |
| Director | 14/10/2022–11/11/2024 | 3 | |
| Director | 18/07/2025–Present | 3 | |
| Director | 11/11/2024–18/07/2025 | 17 | |
| Director | 07/05/2024–04/02/2025 | 0 | |
| Director | 11/11/2024–28/08/2025 | 0 | |
| Secretary | 01/04/2025–01/07/2026 | 0 | |
| Director | 01/04/2025–13/03/2026 | 1 | |
| Director | 19/01/2026–09/03/2026 | 0 |
Persons with significant control
7Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 28/08/2025–Present | 98 | |
| 24/01/2020–05/08/2020 | 1 | |
| 30/03/2021–02/09/2022 | 0 | |
| 08/12/2020–01/04/2021 | 1 | |
| 24/01/2020–05/08/2020 | 1 | |
| 24/01/2020–05/08/2020 | 1 | |
| 26/11/2025–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 54 Since 14/10/2022
- Last 12 months
- 10 -23 vs the year before
- Most recent filing
- 25/09/2026 less than a month ago
What changed in the last year
- Accounts filedLatest 25/09/2026
- Share capital (2)Latest 01/06/2026
- Registered officeLatest 30/04/2026
- Officer changes (4)Latest 17/03/2026
- Confirmation statementLatest 18/02/2026
Filing timeline
- 25/09/2026View PDF (14 pages)
Total exemption full accounts made up to 2025-12-31
- 01/06/2026View PDF (9 pages)
Statement of capital following an allotment of shares on 2026-05-22
- 30/04/2026View PDF (1 pages)
Registered office address changed from Suite 1, the Jeffreys Building, St John's Innovation Park Cowley Road Cambridge Cambridgeshire CB4 0DS United Kingdom to Enhanced Genomics St John's Innovation Centre Cowley Road Cambridge CB4 0WS on 2026-04-30
- 21/03/2026View PDF (1 pages)
Resolutions
- 17/03/2026View PDF (1 pages)
Termination of appointment of Dietrich Stephan as a director on 2026-03-13
- 17/03/2026View PDF (1 pages)
Termination of appointment of Katerina Leftheris as a director on 2026-03-09
- 18/02/2026View PDF (13 pages)
Confirmation statement made on 2026-02-03 with updates
- 17/02/2026View PDF (2 pages)
Appointment of Katerina Leftheris as a director on 2026-01-19
- 01/12/2025View PDF (2 pages)
Notification of Mnl (Parkwalk) Nominees Limited as a person with significant control on 2025-11-26
- 01/12/2025View PDF (9 pages)
Statement of capital following an allotment of shares on 2025-11-26
- 25/09/2025View PDF (2 pages)
Withdrawal of a person with significant control statement on 2025-09-25
- 25/09/2025View PDF (2 pages)
Notification of Bgf Investment Management Limited as a person with significant control on 2025-08-28
Showing 12 of 54 filings
See when the next accounts and confirmation statement are due
Similar companies
34 UK companies are similar to ENHANCED GENOMICS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
CERES HOLOGRAPHICS LIMITED
ActiveSuite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh EH4 2HS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- SC330746
- Incorporated
- 11/09/2007
- Employees
- 22
WEATHERDEN LIMITED
Active264 Banbury Road, Oxford OX2 7DY
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09241011
- Incorporated
- 30/09/2014
- Employees
- 29
LIVER RESEARCH AND DEVELOPMENT LIMITED
Active111 Coldharbour Lane, London SE5 9NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 07944232
- Incorporated
- 09/02/2012
- Employees
- 21
A.M.S. BIOTECHNOLOGY (EUROPE) LIMITED
ActiveMunro House Trafalgar Way, Bar Hill, Cambridge CB23 8SQ
- Activity
- Research and experimental development on biotechnology
- Company no.
- 02117791
- Incorporated
- 31/03/1987
- Employees
- 22
BIODIVERSIFY LTD
Active6 Great North Road, Cromwell, Newark, Nottinghamshire NG23 6JE
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11352631
- Incorporated
- 09/05/2018
- Employees
- 21
About ENHANCED GENOMICS LIMITED
A short description of the company, written from its Companies House record.
ENHANCED GENOMICS LIMITED is a private limited company registered in the United Kingdom, based in Enhanced Genomics St John's Innovation Centre, Cowley Road, Cambridge CB4 0WS. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 6 years 8 months.
The register currently records it as active. Its 2024 accounts report net assets of £3.69M and 28 employees.
ENHANCED GENOMICS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does ENHANCED GENOMICS LIMITED do?
Companies House records ENHANCED GENOMICS LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is ENHANCED GENOMICS LIMITED still active?
ENHANCED GENOMICS LIMITED is recorded as active on the Companies House register, and has been on it since 24/01/2020.
What are ENHANCED GENOMICS LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2024 and report net assets of £3.69M, total assets of £4.61M, cash in bank of £1.93M and total liabilities of £346.53K.
When did ENHANCED GENOMICS LIMITED last file with Companies House?
The most recent document on the record is dated 25/09/2026: Total exemption full accounts made up to 2025-12-31, less than a month ago.
When are ENHANCED GENOMICS LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs ENHANCED GENOMICS LIMITED?
Companies House lists 19 officers (2 currently in post) and 7 people with significant control (2 current).